Tenax Therapeutics, Inc. downgraded to Hold ahead of Aug 2026 phase 3 TNX-103 data in PH-HFpEF; weigh 6MWD odds, downside, ...

Glofitamab produced deep responses in R/R MCL, with ORR 82% and CR 77%, and nearly half of patients maintaining ongoing CR at long follow-up. Outcomes remained clinically meaningful after prior BTK ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

A new study published in the Annals of Internal Medicine journal showed that over a 23-year follow-up period, a once-only ...

Pennsylvania Film Commissioner Gino Anthony Pesi this week announced the Pennsylvania Film Office has awarded $117 million through the Film Production Tax Credit Program to a record 59 projects — ...

Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous system ...

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease ...

More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received ...

Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...

Justice Sonia Sotomayor received more than $4,000 in concert tickets from a Puerto Rican record label that counts Bad Bunny ...

Sanofi’s Cenrifki (tolebrutinib) approved in the EU as the first disability-targeting medicine for secondary progressive multiple sclerosis without relapses ...

Love television history? We identified which 15 shows have the very best cold opens of all time, from sitcoms like The Office ...